Genetic stability of Mycobacterium smegmatis under the stress of first-line antitubercular agents
Dániel Molnár, Éva Viola Surányi, Tamás Trombitás, Dóra Füzesi, Rita Hirmondó, Judit Toth, Musa Ali, Dániel Molnár, Éva Viola Surányi, Tamás Trombitás, Dóra Füzesi, Rita Hirmondó, Judit Toth · 2024
Read Genetic stability of Mycobacterium smegmatis under the stress of first-line antitubercular agents by Dániel Molnár, Éva Viola Surányi, Tamás Trombitás, Dóra Füzesi, Rita Hirmondó, Judit Toth, Musa Ali, Dániel Molnár, Éva Viola Surányi, Tamás Trombitás, Dóra Füzesi, Rita Hirmondó, Judit Toth (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11578590.txt.
Description
Dániel Molnár and co-authors ask whether exposure to tuberculosis drugs makes the tuberculosis family of bacteria mutate faster. Drug resistance in tuberculosis is a growing threat, and one theory blames the drugs themselves for stirring up mutation. The team used a harmless relative, Mycobacterium smegmatis, to test genome stability under first-line drug pressure.
Whole-genome sequencing found no significant rise in mutation rates after long exposure to the drugs. Yet the bacteria adapted quickly in tolerance tests, pointing to non-genetic routes of survival. Genes for DNA repair switched on under treatment, suggesting the cells defend their genome actively when stressed. The authors conclude that, at least in the lab, drug pressure does not drive resistance by accelerating mutation.
Catalog record
| CREATOR | Dániel Molnár, Éva Viola Surányi, Tamás Trombitás, Dóra Füzesi, Rita Hirmondó, Judit Toth, Musa Ali, Dániel Molnár, Éva Viola Surányi, Tamás Trombitás, Dóra Füzesi, Rita Hirmondó, Judit Toth |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 91 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |